Nova Leap Health Corp.
Nova Leap Health Corp. Fundamental Analysis
Nova Leap Health Corp. (NVLPF) shows weak financial fundamentals with a PE ratio of 118.98, profit margin of 0.64%, and ROE of 1.10%. The company generates $0.0B in annual revenue with strong year-over-year growth of 24.29%.
Key Strengths
Areas of Concern
The stock receives a Fundamental Health Score of 45.2/100 based on profitability, valuation, growth, and balance sheet metrics. The D grade reflects weak fundamentals and significant financial concerns.
Fundamental Health Score
We analyze NVLPF's fundamental strength across five key dimensions:
Efficiency Score
WeakNVLPF struggles to generate sufficient returns from assets.
Valuation Score
ModerateNVLPF shows balanced valuation metrics.
Growth Score
ModerateNVLPF shows steady but slowing expansion.
Financial Health Score
ExcellentNVLPF maintains a strong and stable balance sheet.
Profitability Score
ModerateNVLPF maintains healthy but balanced margins.
Key Financial Metrics
Is NVLPF Expensive or Cheap?
P/E Ratio
NVLPF trades at 118.98 times earnings. This suggests a premium valuation.
PEG Ratio
When adjusting for growth, NVLPF's PEG of -0.69 indicates potential undervaluation.
Price to Book
The market values Nova Leap Health Corp. at 1.29 times its book value. This may indicate undervaluation.
EV/EBITDA
Enterprise value stands at 10.65 times EBITDA. This signals the market has high growth expectations.
How Well Does NVLPF Make Money?
Net Profit Margin
For every $100 in sales, Nova Leap Health Corp. keeps $0.64 as profit after all expenses.
Operating Margin
Core operations generate 4.09 in profit for every $100 in revenue, before interest and taxes.
ROE
Management delivers $1.10 in profit for every $100 of shareholder equity.
ROA
Nova Leap Health Corp. generates $0.88 in profit for every $100 in assets, demonstrating efficient asset deployment.
Following the Money - Real Cash Generation
Operating Cash Flow
Nova Leap Health Corp. generates limited operating cash flow of $1.68M, signaling weaker underlying cash strength.
Free Cash Flow
Nova Leap Health Corp. produces free cash flow of $1.44M, offering steady but limited capital for shareholder returns and expansion.
FCF Per Share
Each share generates $0.02 in free cash annually.
FCF Yield
NVLPF converts 5.81% of its market value into free cash.
Financial Ratios Analysis
Valuation Ratios
P/E Ratio
Price to earnings ratio
118.98
vs 25 benchmark
PEG Ratio
Price/earnings to growth ratio
-0.69
vs 25 benchmark
P/B Ratio
Price to book value ratio
1.29
vs 25 benchmark
P/S Ratio
Price to sales ratio
0.76
vs 25 benchmark
Financial Health
Debt/Equity
Total debt to shareholders' equity
0.15
vs 25 benchmark
Current Ratio
Current assets to current liabilities
1.02
vs 25 benchmark
Efficiency Ratios
ROE
Return on equity percentage
0.01
vs 25 benchmark
ROA
Return on assets percentage
0.009
vs 25 benchmark
ROCE
Return on capital employed
0.07
vs 25 benchmark
How NVLPF Stacks Against Its Sector Peers
| Metric | NVLPF Value | Sector Average | Performance |
|---|---|---|---|
| P/E Ratio | 118.98 | 29.38 | Worse (Expensive) |
| ROE | 1.10% | 739.00% | Weak |
| Net Margin | 0.64% | -53619.00% (disorted) | Weak |
| Debt/Equity | 0.15 | 0.39 | Strong (Low Leverage) |
| Current Ratio | 1.02 | 4.03 | Neutral |
| ROA | 0.88% | -20116.00% (disorted) | Weak |
NVLPF outperforms its industry in 1 out of 6 key metrics, but lagging in P/E Ratio.
Historical Growth Performance
5-Year Growth Trajectory
This section reviews Nova Leap Health Corp.'s 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.
Revenue CAGR
37.95%
Industry Style: Defensive, Growth, Innovation
High GrowthEPS CAGR
-111.47%
Industry Style: Defensive, Growth, Innovation
DecliningFCF CAGR
-64.97%
Industry Style: Defensive, Growth, Innovation
Declining